LncRNA WDFY3-AS2 promotes cisplatin resistance and the cancer stem cell in ovarian cancer by regulating hsa-miR-139-5p/syndecan 4 (SDC4) axis [11]. Here, SDC4 is linked to ovarian carcinoma.